BRIEF-Ars Pharmaceuticals Submits SNDA To FDA For Neffy® 1 Mg Dose For Pediatric Patients With Type I Allergic Reactions Who Weigh 15 To 30 KG (33-66 Lbs.)

Reuters09-10

ARS Pharmaceuticals Inc :

* ARS PHARMACEUTICALS SUBMITS SNDA TO FDA FOR NEFFY® 1 MG DOSE FOR PEDIATRIC PATIENTS WITH TYPE I ALLERGIC REACTIONS WHO WEIGH 15 TO 30 KG (33-66 LBS.)

Source text for Eikon: Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466100146?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-10 05:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466100146","market":"us","top_or_hot":-1,"title":"BRIEF-Ars Pharmaceuticals Submits SNDA To FDA For Neffy® 1 Mg Dose For Pediatric Patients With Type I Allergic Reactions Who Weigh 15 To 30 KG (33-66 Lbs.)","media":"Reuters","content":"<html><body><p>ARS Pharmaceuticals Inc   :</p><p>   * ARS PHARMACEUTICALS SUBMITS SNDA TO FDA FOR NEFFY® 1 MG DOSE FOR PEDIATRIC PATIENTS WITH TYPE I ALLERGIC REACTIONS WHO WEIGH 15 TO 30 KG (33-66 LBS.)</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ars Pharmaceuticals Submits SNDA To FDA For Neffy® 1 Mg Dose For Pediatric Patients With Type I Allergic Reactions Who Weigh 15 To 30 KG (33-66 Lbs.)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ars Pharmaceuticals Submits SNDA To FDA For Neffy® 1 Mg Dose For Pediatric Patients With Type I Allergic Reactions Who Weigh 15 To 30 KG (33-66 Lbs.)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-10 05:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ARS Pharmaceuticals Inc   :   * ARS PHARMACEUTICALS SUBMITS SNDA TO FDA FOR NEFFY® 1 MG DOSE FOR PEDIATRIC PATIENTS WITH TYPE I ALLERGIC REACTIONS WHO WEIGH 15 TO 30 KG (33-66 LBS.)Source text for ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNDA","symbol_name":"Senior Living Corp.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2466100146","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466100146","pubTimestamp":1725917506,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"ARS Pharmaceuticals Inc   :   * ARS PHARMACEUTICALS SUBMITS SNDA TO FDA FOR NEFFY® 1 MG DOSE FOR PEDIATRIC PATIENTS WITH TYPE I ALLERGIC REACTIONS WHO WEIGH 15 TO 30 KG (33-66 LBS.)Source text for Eikon:    Further company coverage:","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SNDA":"Senior Living Corp.","SPRY":"ARS PHARMACEUTICALS INC","BK4139":"生物科技","BK4185":"保健护理机构"},"translate_title":"简介-Ars Pharmaceuticals向FDA提交奈菲®1 Mg剂量的SNDA，用于体重15至30 KG（33-66磅）的I型过敏反应儿科患者。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNDA":1,"SPRY":0.9},"content_text":"ARS Pharmaceuticals Inc   :   * ARS PHARMACEUTICALS SUBMITS SNDA TO FDA FOR NEFFY® 1 MG DOSE FOR PEDIATRIC PATIENTS WITH TYPE I ALLERGIC REACTIONS WHO WEIGH 15 TO 30 KG (33-66 LBS.)Source text for Eikon:    Further company coverage:","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466100146"}